DolPHIN-2 presents on postpartum weight changes at CROI 2020

On 9th March 2020, at the virtual CROI conference, DolPHIN-2 investigator Thoko Malaba presented, during a themed discussion, on postpartum weight changes in women initiating dolutegravir versus efavirenz.

This secondary analysis revealed that women taking dolutegravir has more weight gain than those taking efavirenz.  There were also differences in the weight gain between the women in Uganda and South Africa.

A webcast of the presentation is avaiblabe here and you can download the poster here.